These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16309904)

  • 21. Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes.
    de Bethune MP; Nierhaus KH
    Eur J Biochem; 1978 May; 86(1):187-91. PubMed ID: 95947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Styryl-BODIPY based red-emitting fluorescent OFF-ON molecular probe for specific detection of cysteine.
    Shao J; Guo H; Ji S; Zhao J
    Biosens Bioelectron; 2011 Feb; 26(6):3012-7. PubMed ID: 21195598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based drug design meets the ribosome.
    Franceschi F; Duffy EM
    Biochem Pharmacol; 2006 Mar; 71(7):1016-25. PubMed ID: 16443192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition.
    Svetlov MS; Plessa E; Chen CW; Bougas A; Krokidis MG; Dinos GP; Polikanov YS
    RNA; 2019 May; 25(5):600-606. PubMed ID: 30733327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.
    Borovinskaya MA; Pai RD; Zhang W; Schuwirth BS; Holton JM; Hirokawa G; Kaji H; Kaji A; Cate JH
    Nat Struct Mol Biol; 2007 Aug; 14(8):727-32. PubMed ID: 17660832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and functionalization of asymmetrical benzo-fused BODIPY dyes.
    Jiao L; Yu C; Liu M; Wu Y; Cong K; Meng T; Wang Y; Hao E
    J Org Chem; 2010 Sep; 75(17):6035-8. PubMed ID: 20690775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-selective derivatization and remodeling of erythromycin A by using simple peptide-based chiral catalysts.
    Lewis CA; Miller SJ
    Angew Chem Int Ed Engl; 2006 Aug; 45(34):5616-9. PubMed ID: 16858713
    [No Abstract]   [Full Text] [Related]  

  • 28. The ribosome as a drug target.
    Böttger EC
    Trends Biotechnol; 2006 Apr; 24(4):145-7. PubMed ID: 16490268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antibacterial activity of 3-O-acyl-6-O-carbamoyl erythromycin A derivatives.
    Zhu B; Marinelli BA; Abbanat D; Foleno BD; Henninger TC; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1054-9. PubMed ID: 16289812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between the erythromycin and chloramphenicol binding sites on the Escherichica coli ribosome.
    Langlois R; Cantor CR; Vince R; Pestka S
    Biochemistry; 1977 May; 16(11):2349-56. PubMed ID: 324517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes.
    Pestka S; Lemahieu RA
    Antimicrob Agents Chemother; 1974 Oct; 6(4):479-88. PubMed ID: 4157349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ketolides and other macrolide antibiotics].
    Yagisawa M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():234-40. PubMed ID: 12717977
    [No Abstract]   [Full Text] [Related]  

  • 33. Virtual screening and experimental verification to identify potential inhibitors of the ErmC methyltransferase responsible for bacterial resistance against macrolide antibiotics.
    Feder M; Purta E; Koscinski L; Cubrilo S; Maravic Vlahovicek G; Bujnicki JM
    ChemMedChem; 2008 Feb; 3(2):316-22. PubMed ID: 18038381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic blocks mRNA path on the ribosome.
    Mankin A
    Nat Struct Mol Biol; 2006 Oct; 13(10):858-60. PubMed ID: 17021617
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and antimicrobial activity of erythromycin-A oxime analogs.
    Pandey D; Katti SB; Haq W; Tripathi CK
    Bioorg Med Chem; 2004 Jul; 12(14):3807-13. PubMed ID: 15210147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribosome affinity and the prolonged molecular postantibiotic effect of cethromycin (ABT-773) in Haemophilus influenzae.
    Cao Z; Zhong P; Ruan X; Merta P; Capobianco JO; Flamm RK; Nilius AM
    Int J Antimicrob Agents; 2004 Oct; 24(4):362-8. PubMed ID: 15380262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of erythromycin and its combination with protamine hydrochloride on binding of C 14-chloramphenicol with ribosomes of E.coli].
    Belousova II; Lishnevskaia EB; Tereshin IM
    Antibiotiki; 1973 Feb; 18(2):129-31. PubMed ID: 4590904
    [No Abstract]   [Full Text] [Related]  

  • 38. Reaching the target: small molecules aim to probe barrier quality.
    Cordier C; Nelson A
    Chembiochem; 2005 Nov; 6(11):1953-5. PubMed ID: 16231394
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes.
    Pestka S; Lemahieu R; Miller P
    Antimicrob Agents Chemother; 1974 Oct; 6(4):489-91. PubMed ID: 4157350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low affinity for chloramphenicol of erythromycin resistant Escherichia coli ribosomes having an altered protein component.
    Tanaka K; Tamaki M; Takata R; Osawa S
    Biochem Biophys Res Commun; 1972 Mar; 46(6):1979-83. PubMed ID: 4553152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.